| Model Number |
NA-201SX-4022 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Dyspnea (1816); Pneumothorax (2012); Wheezing (4463)
|
| Date of Event |
10/10/2022
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
The suspect device has not been returned to olympus for evaluation.The investigation is in process.The literature article is attached for additional information.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.This report has been submitted by the importer under this mdr report number 2429304-2022-00141.
|
| |
|
Event or Problem Description
|
|
Olympus reviewed the following literature titled "rapid growth of granulation tissue: a rare cause of stridor." a 63 yo f with pmh of 20 pack year tobacco use presented for evaluation of a 2.6cm x 2.4cm rul nodule and mediastinal lymphadenopathy.She underwent navigational bronchoscopy of rul nodule and ebus-tbna for mediastinal staging.Ebus-tbna was performed using an olympus 21g needle at stations 11l, 4l, 7, 4r and 11r.She recovered post-procedure and discharged home.The following evening, she developed shortness of breath and "wheezing¿ which prompted her to report to er.On exam, she had audible inspiratory and expiratory stridor and lungs were clear to auscultation bl.Cxr showed a small right apical pneumothorax which resolved with conservative management.However, her stridor and shortness of breath was unchanged.Thus, repeat flexible bronchoscopy was performed demonstrating interval development of granulation tissue in the lower trachea and in the right main bronchus with complete obstruction of the right main bronchus.The granulation tissue formed at the tbna puncture site at stations 7 and 4r.Ultimately, the granulation tissue was excised using cryotherapy and she was given oral corticosteroids to prevent further development of granulation tissue.Type of adverse events/number of patients: shortness of breath.Wheezing.Pneumothorax.There is no report of any olympus device malfunction in any procedure described in this study.
|
| |
|
Additional Manufacturer Narrative
|
|
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse event cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
|
| |
|
Search Alerts/Recalls
|